The term "DA1 antibody" refers to a specific autoantibody identified in patients with systemic lupus erythematosus (SLE). DA1 and its associated DA2 antibody form precipitin systems targeting nuclear proteins derived from human spleen extracts. DA1 antibodies are rare, appearing in 5% of SLE patients, and are always co-expressed with DA2 antibodies (found in ~22% of SLE cases) . These antibodies are linked to distinct clinical manifestations, including photosensitivity, hepatosplenomegaly, and CNS involvement .
DA1 antibodies are associated with specific pathological features in SLE:
| Clinical Feature | Association with DA1 Antibody |
|---|---|
| Photosensitivity | Increased incidence () |
| Hepatosplenomegaly | Increased incidence () |
| Hemolytic anemia | Increased incidence () |
| Diffuse proliferative glomerulonephritis | Higher prevalence |
| Thrombocytopenia | No direct association (linked to DA2) |
DA1 antibodies produce a speckled staining pattern on HEp2 cells and rat kidney tissues, suggesting reactivity with nuclear antigens . Unlike other SLE-associated antibodies (e.g., anti-Sm or anti-Ro), DA1 exhibits a unique serological profile and is proposed to represent a novel autoantibody system in SLE .
Pathogenic Role: DA1-positive SLE patients show heightened severity, including vasculitis and CNS involvement, compared to DA1-negative cohorts .
Serological Association: DA1 and DA2 antibodies are tightly linked, mirroring relationships seen between other SLE autoantibody pairs (e.g., anti-Sm and anti-nRNP) .
Molecular Targets: While the exact nuclear protein targets of DA1 remain uncharacterized, indirect evidence suggests DA1 may overlap with the previously described MA antibody system .
DA1 antibodies differ from other antibody classes (e.g., IgG, IgE) in structure and function:
| Antibody Type | Molecular Weight | Role |
|---|---|---|
| DA1 (SLE-associated) | Not specified | Autoimmune targeting of nuclear proteins |
| IgG | ~150,000 Da | Primary serum antibody; neutralizes pathogens |
| IgE | ~200,000 Da | Mediates allergic responses |
Unlike therapeutic antibodies (e.g., anti-DLL1 or anti-DDR1 antibodies used in cancer ), DA1 antibodies are strictly pathological and lack direct therapeutic applications.
Identify precise DA1 antigen targets.
Clarify its role in SLE pathogenesis.
Explore potential therapeutic strategies to modulate DA1 activity.
Current diagnostic workflows for SLE should consider DA1/DA2 testing in patients with atypical organ involvement or refractory disease .
The DA1 antibody targets a ubiquitin receptor that plays a crucial role in regulating final seed and organ size by controlling the duration of cell proliferation. Evidence suggests a maternal role in seed mass control, acting synergistically with DA2 to achieve this. This synergistic action extends to restricting cell proliferation within the maternal integuments of ovules and developing seeds. Conversely, DA1 functions antagonistically with UBP15 in a shared pathway to regulate seed size. DA1 physically interacts with UBP15, modulating its stability and influencing cell proliferation in ovules and developing seeds. DA1 functions as a peptidase, cleaving the N-terminal sequences of the E3 ubiquitin-protein ligases BB and DA2 in a ubiquitin-dependent manner. Further peptidase activity is observed through the cleavage of the deubiquitinating enzyme UBP15 (which promotes cell proliferation), and the transcription factors TCP15 and TCP22 (which promote cell proliferation and repress endoreduplication). Beyond its role in growth restriction, DA1 is involved in promoting leaf senescence. Redundancy with DAR1 and DAR2 in regulating endoreduplication during leaf development has also been observed. In collaboration with DAR1 and DAR2, DA1 modulates the protein stability of transcription factors TCP14 and TCP15, which repress endoreduplication by directly regulating the expression of cell-cycle genes.
DA1 antibody is a research reagent developed to detect and study the DA1 protein, which plays a critical role in controlling seed and organ size in plants. The name "DA" derives from the Chinese word meaning "large," reflecting the enlarged phenotype observed in da1-1 mutants . The target protein, DA1, is a 532-amino acid protein in Arabidopsis thaliana that functions to limit the proliferative growth period during early stages of organ development . Unlike antibodies targeting DLL1 (Delta-like protein 1), which is involved in Notch signaling pathways in mammals , DA1 antibody specifically recognizes plant growth regulators.
DA1 antibody has several important applications in plant science research:
Protein detection: Used in Western blot assays to detect DA1 protein expression levels in different plant tissues or developmental stages
Ubiquitin-binding studies: Applied in assays examining the ubiquitin-binding activity of wild-type DA1 and mutant variants like DA1R358K
Immunoprecipitation: Employed to isolate DA1 protein complexes to identify interacting partners
Localization studies: Utilized in immunohistochemistry to determine the subcellular localization of DA1 during plant development
These applications allow researchers to investigate the molecular mechanisms through which DA1 controls organ size and development in plants.
DA1 antibody provides a powerful tool for studying the role of DA1 in controlling plant organ size. Research has shown that da1-1 mutants exhibit increased seed mass (132% of wild type), larger embryos, and increased cotyledon areas . By using DA1 antibody in comparative studies between wild-type and mutant plants, researchers can:
Track DA1 protein levels during developmental transitions
Correlate DA1 expression with cell proliferation arrest
Identify tissues where DA1 is most active in growth regulation
Examine how post-translational modifications affect DA1 function
The antibody allows researchers to move beyond genetic studies to directly investigate protein-level mechanisms controlling plant organ size.
DA1 antibody can be instrumental in studying the ubiquitin-binding properties of DA1 protein, which appears critical to its function. Research has shown that there was no significant difference in ubiquitin-binding activity between GST-DA1 and GST-DA1R358K proteins , despite the R358K mutation causing dramatic phenotypic changes in plant development.
To investigate ubiquitin-binding activity using DA1 antibody, researchers can:
Perform pull-down assays with ubiquitin-conjugated beads
Use DA1 antibody in Western blots to detect wild-type or mutant DA1 proteins retained in ubiquitin-binding assays
Compare binding affinity between different DA1 variants through quantitative immunoblotting
Conduct competitive binding assays using DA1 antibody to detect displacement of DA1 from ubiquitin by other proteins
These approaches help elucidate the molecular mechanism through which DA1 regulates plant organ size via the ubiquitin pathway.
When designing experiments with DA1 antibody for developmental studies, researchers should consider:
Temporal sampling: Since DA1 functions to limit the period of proliferative growth , sampling must capture the critical developmental windows
Tissue specificity: Different organs may show varying patterns of DA1 expression and activity
Genetic backgrounds: Compare wild-type, da1-1 mutant, and complemented lines expressing wild-type DA1 cDNA
Controls: Include appropriate negative controls (pre-immune serum) and positive controls (recombinant DA1 protein)
Analytical methods: Combine immunological techniques with cell cycle markers (e.g., CYCB1;1 reporter fusion) to correlate DA1 function with cell proliferation arrest
A comprehensive experimental design helps resolve contradictory findings and establishes causative relationships between DA1 activity and phenotypic outcomes.
Research has revealed interesting contradictions between genetic and biochemical data regarding DA1 function. For example, the da1-1 mutation (R358K) causes dramatic phenotypic changes despite no significant difference in ubiquitin-binding activity compared to wild-type DA1 . DA1 antibody can help resolve such contradictions through:
Interaction studies: Using DA1 antibody in co-immunoprecipitation experiments to identify differential protein interactions between wild-type and mutant DA1
Conformational analysis: Employing limited proteolysis followed by DA1 antibody detection to examine potential structural differences
Post-translational modification profiling: Analyzing differences in phosphorylation, ubiquitination, or other modifications between wild-type and mutant DA1
Subcellular localization: Determining whether the mutation affects localization, which might not be reflected in simple binding assays
These approaches provide mechanistic insights beyond genetic observations and simple binding studies.
For optimal results when using DA1 antibody in immunodetection assays, researchers should follow these methodological guidelines:
Sample preparation:
Western blotting:
Use appropriate dilution (typically 1:1000-1:5000, but optimize for your specific antibody)
Include positive controls (e.g., recombinant DA1 protein)
Include negative controls (e.g., da1 knockout plant extracts)
Immunohistochemistry:
Fix tissues appropriately (typically 4% paraformaldehyde)
Perform antigen retrieval if necessary
Use secondary antibody controls to verify specificity
Counter-stain nuclei to help determine subcellular localization
These protocols may require optimization for specific plant species, tissues, or developmental stages.
Validating antibody specificity is crucial for reliable research outcomes. For DA1 antibody, consider these validation approaches:
Genetic controls:
Biochemical validation:
Pre-absorption tests with recombinant DA1 protein
Peptide competition assays with the immunizing peptide
Western blot analysis showing a single band of the expected molecular weight
Cross-reactivity assessment:
Test reactivity against related proteins (e.g., DAR1, DAR2)
Evaluate specificity across different plant species if working with non-model organisms
Proper validation ensures experimental results accurately reflect DA1 biology rather than artifacts or cross-reactivity.
Optimal sample preparation is essential for successful DA1 antibody applications:
Protein extraction:
Use buffers containing appropriate detergents (e.g., 0.1% SDS or 1% Triton X-100)
Include protease inhibitors to prevent degradation
Consider phosphatase inhibitors if studying phosphorylation states
Extract at 4°C to minimize protein degradation
Tissue fixation for immunohistochemistry:
For plant tissues, 4% paraformaldehyde is typically effective
Optimize fixation time based on tissue thickness
Consider embedding method based on tissue type (paraffin vs. cryosectioning)
Antigen retrieval methods:
Heat-induced epitope retrieval may be necessary for fixed tissues
Try citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) for heat-mediated antigen retrieval
Test enzymatic retrieval methods if heat-induced methods are unsuccessful
These preparations help preserve epitope structure and accessibility, maximizing antibody performance.
DA1 antibody provides protein-level insights that complement genetic approaches:
Genotype-phenotype correlation:
Temporal resolution:
Genetic approaches may indicate that DA1 controls organ size, but antibody-based studies can pinpoint exactly when and where DA1 protein acts during development
Mechanistic insights:
Interaction networks:
Combine DA1 antibody immunoprecipitation with mass spectrometry to identify DA1 interaction partners, complementing genetic interaction studies
This integration provides a more comprehensive understanding of DA1 function in plant development.
When applying DA1 antibody in cross-species research:
Sequence conservation assessment:
Analyze sequence homology of DA1 between your species of interest and the immunogen used to generate the antibody
Focus on epitope regions if known
Validation in each species:
Perform Western blots to confirm the antibody recognizes a band of appropriate molecular weight
Include positive controls (e.g., Arabidopsis extracts) alongside new species samples
Consider knockout/knockdown controls in the new species if available
Optimization for each species:
Adjust antibody concentration and incubation conditions
Modify extraction buffers based on species-specific tissue characteristics
Test multiple fixation protocols for immunohistochemistry
These considerations help ensure reliable results when extending DA1 research beyond model organisms.
When encountering difficulties with DA1 antibody applications, consider these troubleshooting approaches:
| Challenge | Potential Solutions |
|---|---|
| Weak or no signal in Western blot | - Increase antibody concentration - Extend incubation time - Enhance protein loading - Try different membrane types - Use more sensitive detection methods |
| High background | - Increase blocking time or concentration - Use more stringent washing - Decrease antibody concentration - Try different blocking agents - Pre-absorb antibody with non-specific proteins |
| Multiple bands | - Use fresh samples with protease inhibitors - Optimize sample preparation - Consider native vs. denaturing conditions - Test specificity with knockout controls |
| Inconsistent results | - Standardize protein extraction methods - Control for plant growth conditions - Consider developmental timing - Use internal loading controls |
Systematic troubleshooting can help overcome technical challenges in DA1 antibody applications.
Advanced imaging approaches can significantly extend the utility of DA1 antibody:
Super-resolution microscopy:
Techniques like STORM or PALM can reveal nanoscale localization of DA1 protein
Helpful for studying DA1 distribution within subcellular compartments
Multiplex immunolabeling:
Combine DA1 antibody with antibodies against cell cycle markers or potential interacting proteins
Use spectrally distinct fluorophores to visualize multiple proteins simultaneously
Live cell imaging approaches:
Complement antibody studies with fluorescent protein fusions to DA1
Compare fixed-cell antibody results with live-cell dynamics
3D reconstruction:
Use confocal z-stacks with DA1 antibody staining to create 3D models of DA1 distribution within tissues
Helpful for understanding spatial regulation of plant development
These approaches provide spatial and temporal context to biochemical findings about DA1 function.